Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation.

Yin Y, Huang X, Lynn KD, Thorpe PE.

Cancer Immunol Res. 2013 Oct;1(4):256-68. doi: 10.1158/2326-6066.CIR-13-0073. Epub 2013 Aug 19.


A novel "salting-out" procedure for the isolation of tumor-derived exosomes.

Brownlee Z, Lynn KD, Thorpe PE, Schroit AJ.

J Immunol Methods. 2014 May;407:120-6. doi: 10.1016/j.jim.2014.04.003. Epub 2014 Apr 13.


Anti-VEGF therapy revived by c-Met inhibition, but is c-Met the answer?

Lynn KD, Brekken RA.

Cancer Discov. 2012 Mar;2(3):211-3. doi: 10.1158/2159-8290.CD-12-0037.


GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer.

Lynn KD, Udugamasooriya DG, Roland CL, Castrillon DH, Kodadek TJ, Brekken RA.

BMC Cancer. 2010 Jul 30;10:397. doi: 10.1186/1471-2407-10-397.


VEGF and pleiotrophin modulate the immune profile of breast cancer.

Lynn KD, Roland CL, Brekken RA.

Cancers (Basel). 2010 May 26;2(2):970-88. doi: 10.3390/cancers2020970.


Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.

Roland CL, Lynn KD, Toombs JE, Dineen SP, Udugamasooriya DG, Brekken RA.

PLoS One. 2009 Nov 3;4(11):e7669. doi: 10.1371/journal.pone.0007669.


Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.

Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, Sullivan JP, Shames DS, Brekken RA.

Mol Cancer Ther. 2009 Jul;8(7):1761-71. doi: 10.1158/1535-7163.MCT-09-0280. Epub 2009 Jun 30.


Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS, Beck AW, Barnett CC, Fleming JB, Brekken RA.

Cancer Res. 2008 Jun 1;68(11):4340-6. doi: 10.1158/0008-5472.CAN-07-6705.

Supplemental Content

Support Center